Speaker
Description
TRIUMF's ISAC facility operates ISOL targets under high-power particle irradiation up to 500 MeV and 100 μA of current, producing Radioactive Ion Beams (RIBs) for Canadians and international nuclear and particle physics experiments. The ARIEL facility (Advanced Rare IsotopE Laboratory) is currently under construction with the objective to add two RIBs, in addition to the RIB already being produced by the existing ISAC facility. One ARIEL station will receive a driver beam of 500 MeV protons, up to 100 μA from TRIUMF’s H- cyclotron. The other ARIEL station will utilize an electron beam from the new superconducting linear accelerator, with energy up to 35 MeV and up to 100 kW beam power. The addition of these two ISOL targets enables the delivery of three simultaneous RIB beams to different experiments, while concurrently producing radioisotopes for medical applications.
This contribution will describe the target station and its completion status, and will highlight the recent qualification tests that have been performed on its core components in our offline facility. The predicted beam intensities from the additional two stations will be presented, highlighting the main strengths and weaknesses of this combined facility. Moreover, the current status of the ARIEL facilities will be discussed, along with the roadmap their completion and ramp-up.
| Keyword-1 | ARIEL |
|---|---|
| Keyword-2 | TRIUMF |
| Keyword-3 | RIB |